Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Escribano

Showing results (261-270 of 270) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 270 results.
Advances in Therapy|August 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2024
Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping schemeJesús Guinea, Eva Alcoceba, Eduardo Padilla, et al.
Scientific Reports|March 29, 2022
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertensionAlfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, et al.
European Journal of Heart Failure|March 16, 2023
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of CardiologySuleman Aktaa, Chris P Gale, Margarita Brida, et al.
European Heart Journal|December 28, 2017
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trialJavier Bermejo, Raquel Yotti, Rocío García-Orta, et al.
Respiratory Medicine|February 4, 2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registryHossein-Ardeschir Ghofrani, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
Journal of the American Heart Association|January 5, 2021
Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term SurvivalJavier Bermejo, Ana González-Mansilla, Teresa Mombiela, et al.
Respiratory Medicine|January 10, 2021
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registryMarius M Hoeper, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2022
First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung DiseaseMatina Prapa, Mauro Lago-Docampo, Emilia M Swietlik, et al.
Open Forum Infectious Diseases|December 5, 2022
Global Emergence of Resistance to Fluconazole and Voriconazole in <i>Candida parapsilosis</i> in Tertiary Hospitals in Spain During the COVID-19 PandemicNuria Trevijano-Contador, Alba Torres-Cano, Cristina Carballo-González, et al.
Pageof 27

Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
Advances in Therapy|August 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension StudyOlivier Sitbon, Sandeep Sahay, Pilar Escribano Subías, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2024
Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping schemeJesús Guinea, Eva Alcoceba, Eduardo Padilla, et al.
Scientific Reports|March 29, 2022
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertensionAlfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, et al.
European Journal of Heart Failure|March 16, 2023
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of CardiologySuleman Aktaa, Chris P Gale, Margarita Brida, et al.
European Heart Journal|December 28, 2017
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trialJavier Bermejo, Raquel Yotti, Rocío García-Orta, et al.
Respiratory Medicine|February 4, 2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registryHossein-Ardeschir Ghofrani, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
Journal of the American Heart Association|January 5, 2021
Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term SurvivalJavier Bermejo, Ana González-Mansilla, Teresa Mombiela, et al.
Respiratory Medicine|January 10, 2021
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registryMarius M Hoeper, Miguel-Angel Gomez Sanchez, Marc Humbert, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2022
First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung DiseaseMatina Prapa, Mauro Lago-Docampo, Emilia M Swietlik, et al.
Open Forum Infectious Diseases|December 5, 2022
Global Emergence of Resistance to Fluconazole and Voriconazole in <i>Candida parapsilosis</i> in Tertiary Hospitals in Spain During the COVID-19 PandemicNuria Trevijano-Contador, Alba Torres-Cano, Cristina Carballo-González, et al.
Pageof 27